ACCESSWIRE
06 Aug 2022, 03:25 GMT+10
NEW YORK, NY / ACCESSWIRE / August 5, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Verrica Pharmaceuticals, Inc. (NASDAQ:VRCA)
CONTACT JAKUBOWITZ ABOUT VRCA:
https://claimyourloss.com/securities/verrica-pharmaceuticals-inc-loss-submission-form/?id=30626&from=1
Class Period : May 28, 2021 - May 24, 2022
Lead Plaintiff Deadline : August 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced a bulk solution for the Company's lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Outset Medical, Inc. (NASDAQ:OM)
CONTACT JAKUBOWITZ ABOUT OM:
https://claimyourloss.com/securities/outset-medical-loss-submission-form/?id=30626&from=1
This lawsuit is on behalf of all persons or entities who purchased Outset Medical common stock between September 15, 2020, and June 13, 2022.
Lead Plaintiff Deadline : September 6, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's flagship product, Tablo Hemodialysis System ('Tablo'), would require an additional 510(k) application to be filed with The United States Food and Drug Administration ('FDA'), as defendants had 'continuously made improvements and updates to Tablo over time since its original clearance' (2) as a result, the Company could not conduct a human factors study on a cleared device in accordance with FDA protocols; (3) the Company's inability to conduct the human factors study subjected the Company to the likelihood of the FDA imposing a 'shipment hold' and marketing suspension, leaving the Company unable to sell Tablo for home use; and (4) as a result, defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and /or lacked a reasonable basis at all relevant times.
Enochian BioSciences, Inc. (NASDAQ:ENOB)
CONTACT JAKUBOWITZ ABOUT ENOB:
https://claimyourloss.com/securities/enochian-biosciences-inc-loss-submission-form/?id=30626&from=1
Class Period : January 17, 2018 - June 27, 2022
Lead Plaintiff Deadline : September 26, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's co-founder and inventor Serhat Gumrukcu was engaged in a variety of frauds; (2) Gumrukcu was not a licensed doctor anywhere in the world; (4) as a result of the foregoing, Gumrukcu's purported contributions to the Company lacked a reasonable basis; (5) as a result of the foregoing, the Company had overstated its commercial prospects; (6) Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (7) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
Get a daily dose of Miami Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Miami Mirror.
More InformationSYDNEY, NSW, Australia - Stocks in Asia were mixed on Monday, but gains and losses were modest.There is concern the ...
CANBERRA, Australia: Australia's new government has announced plans to ban the development of a coal mine located near the Great ...
WASHINGTON D.C.: The U.S. Transportation Department said it could require airlines to offer passengers a refund if their flight schedules ...
LONDON, England: In 2023, America's Major League Baseball is set to return to London for the first time since 2019, ...
NEW YORK CITY, New York: A New York Federal Reserve report released this week indicated that Americans are struggling to ...
NEW YORK CITY, New York: The Department of Financial Services of New York State said it has fined the crypto ...
SOLOMON ISLANDS: In a move that opponents said is aimed at controlling and censoring the media, the government of the ...
WASHINGTON D.C.: In July, a Florida man was killed by exploding Takata airbag inflators, possibly becoming the 20th death in ...
Israel has launched an unprovoked war against the Palestinian resistance group Islamic Jihad. The Israeli army assassinated a high-ranking commander ...
ISLAMABAD, Pakistan - Pakistan categorically denied on Thursday that a U.S. drone strike in Kabul that killed al-Qaeda chief Ayman ...
EAST NUSA TENGGARA, Indonesia: Hundreds of Indonesian tourism workers went on strike this week to protest a sharp rise in ...
NASSAU, Bahamas: A team of explorers have announced that they have uncovered a treasure, including coins, gemstones and priceless jewels, ...